Inducing cellular immune responses to human Papillomavirus using peptide and nucleic acid compositions
US7026443B1 · kind B1 · utility
32Cited by
13References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 15, 2000 |
| Grant date | Apr 11, 2006 |
| Priority date | — |
| Expiry date | Mar 26, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2710/20034
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention uses our knowledge of the mechanisms by which antigen is recognized by T cells to identify and prepare human papillomavirus (HPV) epitopes, and to develop epitope-based vaccines directed towards HPV. More specifically, this application communicates our discovery of pharmaceutical compositions and methods of use in the prevention and treatment of HPV infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.